Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Sundar, Raghav  [Clear All Filters]
2024
Shitara K, Falcone A, Fakih MG, George B, Sundar R, Ranjan S, Van Cutsem E. Efficacy and Safety of Trifluridine/Tipiracil-Containing Combinations in Colorectal Cancer and Other Advanced Solid Tumors: A Systematic Review. Oncologist. 2024.
2023
Choo J, Kua LFang, Soe MYar, Asuncion BReyna, Tan BKye Jyn, Teo CBoon, Tay RYong Kiat, So J, Shabbir A, Guowei K, et al. Clinical relevance of PD-1 positive CD8 T-cells in gastric cancer. Gastric Cancer. 2023.
Xu C, Huang KKyon, Law JHao, Chua JShijia, Sheng T, Flores NM, Pizzi MPool, Okabe A, Tan ALay Keng, Zhu F, et al. Comprehensive molecular phenotyping of -deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities. Gut. 2023.
Tan WChong, Tan JYu Jin, Lim JSi Jing, Tan RYing Cong, Bin Lee ARyan Yan, Leong FLoon, Lee SChin, Chai LYi Ann, Tan TTong, Malek MIsmail Bin, et al. COVID-19 Severity and Waning Immunity After up to 4 mRNA Vaccine Doses in 73 608 Patients With Cancer and 621 475 Matched Controls in Singapore: A Nationwide Cohort Study. JAMA Oncol. 2023.
Walsh RJ, Sundar R, Lim JSJ. Immune checkpoint inhibitor combinations-current and emerging strategies. Br J Cancer. 2023.
2022
Yap DWei Ting, Leone AGiovanni, Wong NZhun Hong, Zhao JJ, Tey JChee Seong, Sundar R, Pietrantonio F. Effectiveness of Immune Checkpoint Inhibitors in Patients With Advanced Esophageal Squamous Cell Carcinoma: A Meta-analysis Including Low PD-L1 Subgroups. JAMA Oncol. 2022.
Gwee YXiang, Chia DKai Ann, So J, Ceelen W, Yong WPeng, Tan P, Ong C-AJohnny, Sundar R. Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis. J Clin Oncol. 2022:JCO2102745.
Ho SWei Ting, Sheng T, Xing M, Ooi WFong, Xu C, Sundar R, Huang KKyon, Li Z, Kumar V, Ramnarayanan K, et al. Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilities. Gut. 2022.
Chia DKai Ann, Gwee YXiang, Sundar R. Resistance to systemic immune checkpoint inhibition in the peritoneal niche. J Immunother Cancer. 2022;10(6).
Loh J, Ang YLi En, Jain A, Yeong J, Sundar R. Targeting Anaplastic Lymphoma Kinase in GI Primary Malignancies. JCO Precis Oncol. 2022;6:e2200208.